News & Analysis on Clinical Trial Services & Contract Research And Development
As it consolidates its manufacturing operations in the US, Watson Pharmaceuticals has received a warning letter from the US Food and Drug Administration (FDA) accusing it of using the wrong ingredients in the production of capsules, failing to prevent...
Outourcing-Pharma focus on: FDA clinical trial initiatives
The US Food and Drug Administration (FDA) has signalled it will soon allow a new "adaptive" approach to clinical trials in order to streamline drug testing and speed drugs to market.
European researchers have not only devised a new diagnostic lab tool for prostate cancer but have also identified a new molecular marker that makes the identification of the disease much quicker.
After a ruthless battle between US states, Novartis has selected Holly Springs in North Carolina for its vaccine manufacturing plant which will use novel cell culture technology to dramatically speed up production - the first facility in the US to do so.
Irish pharmaceutical specialist Guy & Co has been strengthened by the recent acquisition of leading US-based pharmaceutical packaging specialist Pharmagraphics according to its parent company and will now be known as Pharmagraphics Guy.
In-PharmaTechnologist Excipient GMP Series
Specialty chemicals firm Cognis has received good manufacturing practice (GMP) certification for its production of pharmaceutical excipients in Germany, the first chemical company in the world to do so but certainly not the last.
Momentum is growing at the UK's new National Biomanufacturing Centre (NBC) as its operator Eden Biodesign inked a second contract at the centre - set up to establish England's Northwest as one of the top biomanufacturing hubs in Europe.
The Japanese pharmaceutical industry is eyeing India as a new hub to conduct its contract manufacturing and clinical trials - India is thirsty for new Japanese investment.